Nurse Practitioner in Palisades Park, NJ Accepting Medicare

6 Nurse Practitioner nurses found. Showing 1 - 6

Ms. Riddhi Shah, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 9 Delia Blvd Unit A, Palisades Park, NJ 07650 Phone: 909-348-3236

Moon Hee Yum, NP Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 800 12th St Apt 205, Palisades Park, NJ 07650 Phone: 201-316-4307

Sun Young Lee, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 11 West Harriet Ave, Apt 102, Palisades Park, NJ 07650 Phone: 917-651-8339

Mrs. Eunsol Cho Lee, APN Nurse Practitioner - Gerontology Medicare: Medicare Enrolled Practice Location: 7 Broad Ave Ste 203, Palisades Park, NJ 07650 Phone: 201-941-2486

Hyeyoung Park, Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 118 Broad Ave, Ste N10, Palisades Park, NJ 07650 Phone: 201-313-1122    Fax: 201-941-1157

Mrs. Soonhee Pieh, NP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 11 E Harwood Ter, Palisades Park, NJ 07650 Phone: 201-313-1500

News Archive

Study sheds light on role of group therapy for medically unexplained symptoms

Compared to pure general practitioners training, collaborative group intervention achieved a progressive, clinically meaningful improvement in mental but not physical patients' quality of life. This result could bridge gaps between general practice and mental health care.

Primary care visits lead to more screenings and follow-up colonoscopies

People who visit their primary care physicians are more likely to get potentially life-saving colon cancer screenings and follow up on abnormal stool blood test results - even in health systems that heavily promote mail-in home stool blood tests that don't require a doctor visit, a study involving UT Southwestern population health researchers shows.

Positive top-line results from Targacept's TC-5619 Phase 2 trial in adults with ADHD

Targacept, Inc today announced top-line results from a Phase 2 proof of concept trial of TC-5619 as a treatment for adults with attention deficit/hyperactivity disorder.

New Type 1 Diabetes competitive landscape map released by TechAtlas Group

TechAtlas Group has announced the release of the latest Type 1 Diabetes competitive landscape map. This particular landscape highlights 71 international companies with over 140 drugs and devices currently on the market and in development.

Read more Medical News

› Verified 2 days ago